Publications by authors named "David S Herman"

Claim this Profile
T
Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease.
Benoît Melchior, Gopi Kumar Mittapalli, Carolyn Lai, Karen Duong-Polk, Joshua Stewart, David S Herman

Aging Cell· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of descending pain-facilitatory pathways from the rostral ventromedial medulla by cholecystokinin elicits release of prostaglandin-E₂ in the spinal cord.
Timothy M Marshall, David S Herman, Tally M Largent-Milnes, Hamid Badghisi, Konstantina Zuber

Pain· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance.
Jennifer Y Xie, David S Herman, Carl-Olav Stiller, Luis R Gardell, Michael H Ossipov

J Neurosci· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis